Effects of the K+ channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral system in patients with stable angina pectoris. A comparison with the β blocker atenolol;Auswirkungen des K+-kanalblockers tedisamil auf hamodynamik, myokardischamie und neurohumorales system bei patienten mit stabiler angina pectoris. Ein vergleich mit dem β-blocker atenolol

Zeitschrift fur Kardiologie

Volumn 88, Issue 10, 1999, Pages 838-849

  Mitrovic, V ^a   Miskovic, A ^a   Straub, M ^b   Beckmann, K ^b   Thormann, J ^a   Pitschner, H ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

Beta blockers; Catecholamines; Coronary artery disease; Hemodynamics; Right heart catheterization; Tedisamil

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; NEUROHORMONE; POTASSIUM CHANNEL BLOCKING AGENT; TEDISAMIL; ANTIARRHYTHMIC AGENT; CYCLOPROPANE DERIVATIVE; FUSED HETEROCYCLIC RINGS; NORADRENALIN;

ADULT; AGED; ANGINA PECTORIS; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LUNG CAPILLARY PRESSURE; MALE; POTASSIUM CURRENT; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; EXERCISE TEST; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; ANTI-ARRHYTHMIA AGENTS; ATENOLOL; BICYCLO COMPOUNDS, HETEROCYCLIC; CORONARY CIRCULATION; CYCLOPROPANES; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; NOREPINEPHRINE; POTASSIUM CHANNEL BLOCKERS; TREATMENT OUTCOME;

EID: 0032585980     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050360     Document Type: Article

References (32)

1. Adaikan G, Beatch G, Lee T, Ratnam S, Walker M (1992) Antiarrhythmic actions of tedisamil: Studies in rats and primates. Car diovasc Drags Ther 6:345-352
2. + current blocker. Br J Pharmacol 102:13-18
3. Binkley PF, Lewe RF, Lima JJ, Abdulkader AA, Unverferth DV, Leier CV (1986) Hemodynamic-inotropic response to β-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy. Circulation 74:1390-1398
4. Bril A, Landais L, Gout B (1993) Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo. Cardiovasc Drugs Ther 7:233-240
5. Buschmann G, Kühl UG, Varchmin G, Ziegler D (1988) In vitro and in vivo bradycardic activities of KC 8857 (Abstract). Naunyn Schmiedebergs Arch Pharmacol 338 (suppl):R49
6. Chi L, Park JL, Friedrichs GS, Banglawala YA, Perez MA, Tanhehco EJ, Lucchesi BR (1996) Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart. Br J Pharmacol 117:1261-1269
7. Duchosal F, Opie LH (1987) KC 8857, a new compound with combined bradycardic and positive inotropic effects (Abstract). J Mol Cell Cardiol 19 (suppl III): 19
8. + current in rat ventricular myocytes. Am J Physiol 257:H1746-H1749
9. + currents in mammalian cardiac and glial cells. Pharmacol Exp Ther 254:560-569
10. + channels in adult rat ventricular cells. Mol Cell Cardiol 24 (suppl VI):S40
11. Friedrichs GS, Abreu JN, Cousins GR, Kerrick GP, Chi L, Lucchesi BR (1996) Tedisamil protects against ventricular fibrillation in a conscious canine model of sudden cardiac death. Faseb-Journal 10 (3):a33
12. Gazes PC, Richardson JA, Woods EF (1959) Plasma catecholamine concentrations in myocardial infarction and angina pectoris. Circulation 19:657-661
13. Huckauf H (1984) Über die Wirkung der β-Rezeptorenblocker im normalen und obstructiven Atemwegssystem. Textbook: Lohmann FW. Die klinische Bedeutung der β1-Selectivität; Verlag für angewandte Wissenschaften, S 143-151
14. Kobinger W (1985) Specific bradycardic agents, a new approach to therapy in angina pectoris. Prog Pharmacol 54:89-100
15. Kringe KP, Greb H, Bayha G, Kranich S, Mitrovic V (1986) HPLC-Routincanalytic von freiem Noradrenalin und Adrenalin. Ihre Bestimmung in Plasma, Urin und Gewebe mittels Hochlcistungsflüssigkeits-chromatographic und elektrochemischer Detektion. LABo-Fachzeitschrift für Labortechnik 17:7-12
16. Laurent D, Bolene-Williams C, Williams FL, Katz NL (1956) Effects of heart rate on coronary flow and cardiac oxygen consumption. Am J Physiol 185:355-364
17. McLarnon J (1990) Block by a putative antiarrhythmic agent or a calcium-dependent potassium channel in cultured hippocampal neurons. Ncurosci Lett 12:210-215
18. Mitrovic V, Oehm E, Liebrich A, Thormann J, Schlepper M (1992) Hemodynamic and antiischemic effects of tedisamil in humans. Cardiovasc Drugs Thor 6:353-360
19. Mitrovic V, Oehm E, Stressor R, Schlepper M, Pitschner HF (1996) Der neue Kalium-Kanalblocker Tedisamil und seine hämodynamische, antiischämische und neurohumorale Wirkung bei Patienten mit koronarer Herzerkrankung. Z Kardiol 85:961-972
20. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M, Inoue M, Hori M, Kamada T (1995) Roles of alpha 1-adrenoceptor activity in the release of nitric oxide during ischemia of the canine heart. Biochem and Biophys Res Com 212 (3):1133-1138
21. Ohler A, Amos G, Wettwer E, Ravens U (1994) Frequency dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: No evidence for "reverse frequency dependent" block. Naunyn-Schmiedeberg's Arch Pharmacol 349:602-610
22. + channels in membrane patches from smooth muscle cells of the guinea pig portal vein. Pflügers Arch 418:308-312
23. + current in single smooth muscle cells of the guinea pig portal vein. Pflügers Arch 421:22-25
24. Rardon DP, Bailey JC (1983) Parasympathetic effects on electrophysiologic properties of cardiac ventricular tissue. J Am Coll Cardiol 2 (6): 1200-1209
25. Remme WJ, de Leeuw PW, Bootsma M, Look MP, Kruijssen D (1991) Systemic neurohormonal activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris. Am J Cardiol 68:181-186
26. Rooke GA, Feigl EO (1982) Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 50:273-286
27. Schamhardt HC, Verdouw PD, Saxena PR (1981) Improvement of perfusion and function of ischemic porcine myocardium after reduction of heart rate by alinidine. J Cardiovasc Pharmacol 3:728-738
28. Schwarz P, Diem R, Dun NJ, Foerstermann U (1995) Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res 77 (4):841-848
29. Thormann J, Mitrovic V, Riedel H, Neutzner J, Strasser R, Behavar H, Schlepper M (1993) Tedisamil (KC 8857) is a new specific bradycardic drug: Does it also influence myocardial contractility? Analysis by the conductance (vulume) technique in coronary artery disease. Am Heart J 125:1233
30. Verdouw PD, Dunker DJ, Heere TJM, Saxena PR (1987) Changes in systemic hemodynamics, regional myocardial function and perfusion induced by Alinidine in pigs with and without narrowed coronary arteries. Eur Heart J 8:43-52
31. Wallace A, Stupienski RF, Baskin E, Appleby S, Kothstein T, Gehret J, King W, Romy D, Lynch J (1995) Cardiac electro-physiologic and antiarrhythmic actions of tedisamil. J Pharm Exper Ther 273: 168-175
32. Weber KT, Janiki JS (1979) The metabolic demand and oxygen supply of the heart. Physiologic and clinical considerations. Am J Cardiol 44:722-729